tiprankstipranks
Trending News
More News >
Palvella Therapeutics (PVLA)
NASDAQ:PVLA
US Market

Palvella Therapeutics (PVLA) Income Statement

Compare
703 Followers

Palvella Therapeutics Income Statement

Last quarter (Q3 2025), Palvella Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Palvella Therapeutics's net income was $-11.35M. See Palvella Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 25.90M$ 31.42M$ 29.32M
Gross Profit
$ 0.00$ 0.00$ 23.12M$ 29.05M$ 29.32M
Operating Expenses
$ 14.10M$ 11.87M$ 66.60M$ 80.88M$ 61.12M
Depreciation and Amortization
$ 0.00$ 0.00$ 2.78M$ 2.37M$ 2.13M
EBITDA
$ -13.12M$ 18.69M$ -30.50M$ -43.37M$ -34.94M
Operating Income
$ -14.10M$ -11.87M$ -43.47M$ -51.83M$ -33.92M
Other Income/Expenses
$ -3.34M$ 30.56M$ 10.20M$ 6.09M$ -3.15M
Pretax Income
$ -17.43M$ 18.69M$ -33.28M$ -45.74M$ -37.07M
Net Income
$ -17.43M$ 18.69M$ -33.28M$ -45.74M$ -37.23M
Per Share Metrics
Basic EPS
$ -7.83$ 14.74$ -29.61$ -56.69$ -54.67
Diluted EPS
$ -7.83$ 14.74$ -29.61$ -56.69$ -54.67
Weighted Average Shares Outstanding
2.23M 1.27M 930.35K 806.84K 681.01K
Weighted Average Shares Outstanding (Diluted)
2.23M 1.27M 930.35K 806.84K 681.01K
Currency in USD

Palvella Therapeutics Earnings and Revenue History